Urist's 1965 landmark paper asks whether acellular, devitalized, decalcified bone matrix can induce new bone formation when implanted in muscle, with no living donor cells present. Using roughly 70 experiments across approximately 300 animals, he characterizes the full cellular sequence of this phenomenon and coins the term 'autoinduction.' The paper provides the experimental foundation for the later discovery of bone morphogenetic proteins and the entire field of bone graft biology.
Every demineralized bone matrix product on the shelf — and every clinical application of recombinant BMP-2 or BMP-7 in spine fusion and fracture care. Traces its biological rationale to this single paper.
When you choose between bone graft options, this paper is why decalcification matters: undecalcified dead bone induces osteogenesis only rarely and after months of latency, while decalcified matrix achieves >90% induction within weeks.
Urist's oxygen-tension principle is also clinically actionable: creating a well-vascularized, open wound environment favors osteogenesis, while compacted, hypoxic spaces favor cartilage. A concept that informs both graft bed preparation and the biology of fracture nonunion.
In 1971, Urist and Strates built directly on this work to name 'bone morphogenetic protein' and formalize the term 'osteoinduction.' By the 1990s, at least 15 BMPs had been identified as TGF-β superfamily members, and Wozney's 1988 gene sequencing enabled recombinant production of the rhBMP-2 used in clinical practice today.
Urist's 1965 landmark paper asks whether acellular, devitalized, decalcified bone matrix can induce new bone formation when implanted in muscle, with no living donor cells present. Using roughly 70 experiments across approximately 300 animals, he characterizes the full cellular sequence of this phenomenon and coins the term 'autoinduction.' The paper provides the experimental foundation for the later discovery of bone morphogenetic proteins and the entire field of bone graft biology.
Every demineralized bone matrix product on the shelf — and every clinical application of recombinant BMP-2 or BMP-7 in spine fusion and fracture care. Traces its biological rationale to this single paper.
When you choose between bone graft options, this paper is why decalcification matters: undecalcified dead bone induces osteogenesis only rarely and after months of latency, while decalcified matrix achieves >90% induction within weeks.
Urist's oxygen-tension principle is also clinically actionable: creating a well-vascularized, open wound environment favors osteogenesis, while compacted, hypoxic spaces favor cartilage. A concept that informs both graft bed preparation and the biology of fracture nonunion.
In 1971, Urist and Strates built directly on this work to name 'bone morphogenetic protein' and formalize the term 'osteoinduction.' By the 1990s, at least 15 BMPs had been identified as TGF-β superfamily members, and Wozney's 1988 gene sequencing enabled recombinant production of the rhBMP-2 used in clinical practice today.